Natural antimicrobial susceptibility patterns and biochemical identification of Escherichia albertii and Hafnia alvei strains

Bangladeshi diarrheagenic Hafnia alvei-like strains have been described recently as the new species Escherichia albertii ( Int J Syst Evolut Microbiol. 2003;53:807–810). The natural susceptibility of 21 E. albertii and 76 H. alvei strains to 69 antimicrobial agents was examined, applying a microdilu...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Diagnostic microbiology and infectious disease 2005-03, Vol.51 (3), p.151-163
Hauptverfasser: Stock, Ingo, Rahman, Motiur, Sherwood, Kimberley Jane, Wiedemann, Bernd
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 163
container_issue 3
container_start_page 151
container_title Diagnostic microbiology and infectious disease
container_volume 51
creator Stock, Ingo
Rahman, Motiur
Sherwood, Kimberley Jane
Wiedemann, Bernd
description Bangladeshi diarrheagenic Hafnia alvei-like strains have been described recently as the new species Escherichia albertii ( Int J Syst Evolut Microbiol. 2003;53:807–810). The natural susceptibility of 21 E. albertii and 76 H. alvei strains to 69 antimicrobial agents was examined, applying a microdilution procedure in IsoSensitest broth (for all the strains) and cation-adjusted Mueller-Hinton broth (for some strains). Examining the phenotypic features of both taxa with commercial identification systems and conventional tests, a database for an accurate biochemical separation of E. albertii from H. alvei was also established. Both taxa were naturally sensitive or sensitive and of intermediate susceptibility to aminoglycosides, acylureidopenicillins, ticarcillin, several cephalosporins, carbapenems, aztreonam, quinolones, folate pathway inhibitors, and nitrofurantoin. They were naturally resistant to tetracycline, penicillin G, oxacillin, all macrolides except for azithromycin, lincosamides, streptogramins, glycopeptides, rifampicin, and fusidic acid. Taxon-related differences in natural susceptibility affecting clinical assessment criteria were seen with doxycycline, minocycline, aminopenicillins, some cephalosporins, azithromycin, and fosfomycin. E. albertii was more susceptible than H. alvei to these agents and was naturally sensitive to all β-lactams (except for penicillin G and oxacillin), azithromycin, and fosfomycin. H. alvei was naturally resistant or of intermediate susceptibility to all tetracyclines, amoxicillin, amoxicillin-clavulanate, ampicillin-sulbactam, narrow-spectrum cephalosporins, azithromycin, and fosfomycin. Motile malonate-negative Hafnia strains (indicating genospecies 2 of the H. alvei complex) were less susceptible to some cephalosporins than nonmotile, malonate-positive hafniae (indicating genospecies 1). Proline deaminase, hydroxyproline amidase, tripeptidase, chitinase, Voges-Proskauer reaction, and assimilation of histidine as well as acid production from glycerol, rhamnose, and xylose were suitable tests to separate strains of E. albertii from those of the H. alvei complex. Although out of the scope of this study, it should be noted that several strains of E. albertii showed acquired resistances to some penicillins and antifolates.
doi_str_mv 10.1016/j.diagmicrobio.2004.10.008
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67514154</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0732889304002299</els_id><sourcerecordid>67514154</sourcerecordid><originalsourceid>FETCH-LOGICAL-c505t-8b93336e346bd025ab829e92894c353fbbb202b68672d68264ad947427ac54f03</originalsourceid><addsrcrecordid>eNqNkUtv1DAUhS0EosPAX0AREuwyvX7EdtihtrSVKropa8t2HHpHmWSwnUpd8N_xdCK1O1j5cb9zr30OIZ8obChQebrddGh_7dDHyeG0YQCiFDYA-hVZUa3aGkDBa7ICxVmtdctPyLuUtgCUtQLekhPaKCklwIr8-WHzHO1Q2THj0rKc0px82Gd0OGB-rPY25xDHVKiuKjP9fShs4bALRdeXfcZprKa-ukilGNHfo63s4ELMiE-yK9uPT3cPAauUo8UxvSdvejuk8GFZ1-Tn94u7s6v65vby-uzbTe0baHKtXcs5l4EL6TpgjXWataFluhWeN7x3zjFgTmqpWCc1k8J2rVCCKesb0QNfky_Hvvs4_Z5DymaH5YPDYMcwzclI1VBBG_FPkCrN6cHRNfl6BItjKcXQm33EnY2PhoI5pGS25mVK5pDSoVZSKuKPy5TZ7UL3LF1iKcDnBbCp2NxHO3pMz1yhaFvSXZPzIxeKeQ8Yokkew-hDhzH4bLoJ_-c9fwE30rkl</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17831889</pqid></control><display><type>article</type><title>Natural antimicrobial susceptibility patterns and biochemical identification of Escherichia albertii and Hafnia alvei strains</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Stock, Ingo ; Rahman, Motiur ; Sherwood, Kimberley Jane ; Wiedemann, Bernd</creator><creatorcontrib>Stock, Ingo ; Rahman, Motiur ; Sherwood, Kimberley Jane ; Wiedemann, Bernd</creatorcontrib><description>Bangladeshi diarrheagenic Hafnia alvei-like strains have been described recently as the new species Escherichia albertii ( Int J Syst Evolut Microbiol. 2003;53:807–810). The natural susceptibility of 21 E. albertii and 76 H. alvei strains to 69 antimicrobial agents was examined, applying a microdilution procedure in IsoSensitest broth (for all the strains) and cation-adjusted Mueller-Hinton broth (for some strains). Examining the phenotypic features of both taxa with commercial identification systems and conventional tests, a database for an accurate biochemical separation of E. albertii from H. alvei was also established. Both taxa were naturally sensitive or sensitive and of intermediate susceptibility to aminoglycosides, acylureidopenicillins, ticarcillin, several cephalosporins, carbapenems, aztreonam, quinolones, folate pathway inhibitors, and nitrofurantoin. They were naturally resistant to tetracycline, penicillin G, oxacillin, all macrolides except for azithromycin, lincosamides, streptogramins, glycopeptides, rifampicin, and fusidic acid. Taxon-related differences in natural susceptibility affecting clinical assessment criteria were seen with doxycycline, minocycline, aminopenicillins, some cephalosporins, azithromycin, and fosfomycin. E. albertii was more susceptible than H. alvei to these agents and was naturally sensitive to all β-lactams (except for penicillin G and oxacillin), azithromycin, and fosfomycin. H. alvei was naturally resistant or of intermediate susceptibility to all tetracyclines, amoxicillin, amoxicillin-clavulanate, ampicillin-sulbactam, narrow-spectrum cephalosporins, azithromycin, and fosfomycin. Motile malonate-negative Hafnia strains (indicating genospecies 2 of the H. alvei complex) were less susceptible to some cephalosporins than nonmotile, malonate-positive hafniae (indicating genospecies 1). Proline deaminase, hydroxyproline amidase, tripeptidase, chitinase, Voges-Proskauer reaction, and assimilation of histidine as well as acid production from glycerol, rhamnose, and xylose were suitable tests to separate strains of E. albertii from those of the H. alvei complex. Although out of the scope of this study, it should be noted that several strains of E. albertii showed acquired resistances to some penicillins and antifolates.</description><identifier>ISSN: 0732-8893</identifier><identifier>EISSN: 1879-0070</identifier><identifier>DOI: 10.1016/j.diagmicrobio.2004.10.008</identifier><identifier>PMID: 15766600</identifier><identifier>CODEN: DMIDDZ</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>Anti-Bacterial Agents - pharmacology ; Antimicrobial susceptibility ; Bacteriology ; Biological and medical sciences ; Biomarkers ; Drug Resistance, Bacterial ; Escherichia - classification ; Escherichia - drug effects ; Escherichia albertii ; Fundamental and applied biological sciences. Psychology ; Hafnia alvei ; Hafnia alvei - classification ; Hafnia alvei - drug effects ; Infectious diseases ; Medical sciences ; Microbial Sensitivity Tests ; Microbiology ; Miscellaneous ; Species Specificity</subject><ispartof>Diagnostic microbiology and infectious disease, 2005-03, Vol.51 (3), p.151-163</ispartof><rights>2005 Elsevier Inc.</rights><rights>2005 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c505t-8b93336e346bd025ab829e92894c353fbbb202b68672d68264ad947427ac54f03</citedby><cites>FETCH-LOGICAL-c505t-8b93336e346bd025ab829e92894c353fbbb202b68672d68264ad947427ac54f03</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.diagmicrobio.2004.10.008$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=16661907$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15766600$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Stock, Ingo</creatorcontrib><creatorcontrib>Rahman, Motiur</creatorcontrib><creatorcontrib>Sherwood, Kimberley Jane</creatorcontrib><creatorcontrib>Wiedemann, Bernd</creatorcontrib><title>Natural antimicrobial susceptibility patterns and biochemical identification of Escherichia albertii and Hafnia alvei strains</title><title>Diagnostic microbiology and infectious disease</title><addtitle>Diagn Microbiol Infect Dis</addtitle><description>Bangladeshi diarrheagenic Hafnia alvei-like strains have been described recently as the new species Escherichia albertii ( Int J Syst Evolut Microbiol. 2003;53:807–810). The natural susceptibility of 21 E. albertii and 76 H. alvei strains to 69 antimicrobial agents was examined, applying a microdilution procedure in IsoSensitest broth (for all the strains) and cation-adjusted Mueller-Hinton broth (for some strains). Examining the phenotypic features of both taxa with commercial identification systems and conventional tests, a database for an accurate biochemical separation of E. albertii from H. alvei was also established. Both taxa were naturally sensitive or sensitive and of intermediate susceptibility to aminoglycosides, acylureidopenicillins, ticarcillin, several cephalosporins, carbapenems, aztreonam, quinolones, folate pathway inhibitors, and nitrofurantoin. They were naturally resistant to tetracycline, penicillin G, oxacillin, all macrolides except for azithromycin, lincosamides, streptogramins, glycopeptides, rifampicin, and fusidic acid. Taxon-related differences in natural susceptibility affecting clinical assessment criteria were seen with doxycycline, minocycline, aminopenicillins, some cephalosporins, azithromycin, and fosfomycin. E. albertii was more susceptible than H. alvei to these agents and was naturally sensitive to all β-lactams (except for penicillin G and oxacillin), azithromycin, and fosfomycin. H. alvei was naturally resistant or of intermediate susceptibility to all tetracyclines, amoxicillin, amoxicillin-clavulanate, ampicillin-sulbactam, narrow-spectrum cephalosporins, azithromycin, and fosfomycin. Motile malonate-negative Hafnia strains (indicating genospecies 2 of the H. alvei complex) were less susceptible to some cephalosporins than nonmotile, malonate-positive hafniae (indicating genospecies 1). Proline deaminase, hydroxyproline amidase, tripeptidase, chitinase, Voges-Proskauer reaction, and assimilation of histidine as well as acid production from glycerol, rhamnose, and xylose were suitable tests to separate strains of E. albertii from those of the H. alvei complex. Although out of the scope of this study, it should be noted that several strains of E. albertii showed acquired resistances to some penicillins and antifolates.</description><subject>Anti-Bacterial Agents - pharmacology</subject><subject>Antimicrobial susceptibility</subject><subject>Bacteriology</subject><subject>Biological and medical sciences</subject><subject>Biomarkers</subject><subject>Drug Resistance, Bacterial</subject><subject>Escherichia - classification</subject><subject>Escherichia - drug effects</subject><subject>Escherichia albertii</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Hafnia alvei</subject><subject>Hafnia alvei - classification</subject><subject>Hafnia alvei - drug effects</subject><subject>Infectious diseases</subject><subject>Medical sciences</subject><subject>Microbial Sensitivity Tests</subject><subject>Microbiology</subject><subject>Miscellaneous</subject><subject>Species Specificity</subject><issn>0732-8893</issn><issn>1879-0070</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkUtv1DAUhS0EosPAX0AREuwyvX7EdtihtrSVKropa8t2HHpHmWSwnUpd8N_xdCK1O1j5cb9zr30OIZ8obChQebrddGh_7dDHyeG0YQCiFDYA-hVZUa3aGkDBa7ICxVmtdctPyLuUtgCUtQLekhPaKCklwIr8-WHzHO1Q2THj0rKc0px82Gd0OGB-rPY25xDHVKiuKjP9fShs4bALRdeXfcZprKa-ukilGNHfo63s4ELMiE-yK9uPT3cPAauUo8UxvSdvejuk8GFZ1-Tn94u7s6v65vby-uzbTe0baHKtXcs5l4EL6TpgjXWataFluhWeN7x3zjFgTmqpWCc1k8J2rVCCKesb0QNfky_Hvvs4_Z5DymaH5YPDYMcwzclI1VBBG_FPkCrN6cHRNfl6BItjKcXQm33EnY2PhoI5pGS25mVK5pDSoVZSKuKPy5TZ7UL3LF1iKcDnBbCp2NxHO3pMz1yhaFvSXZPzIxeKeQ8Yokkew-hDhzH4bLoJ_-c9fwE30rkl</recordid><startdate>20050301</startdate><enddate>20050301</enddate><creator>Stock, Ingo</creator><creator>Rahman, Motiur</creator><creator>Sherwood, Kimberley Jane</creator><creator>Wiedemann, Bernd</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>C1K</scope><scope>7X8</scope></search><sort><creationdate>20050301</creationdate><title>Natural antimicrobial susceptibility patterns and biochemical identification of Escherichia albertii and Hafnia alvei strains</title><author>Stock, Ingo ; Rahman, Motiur ; Sherwood, Kimberley Jane ; Wiedemann, Bernd</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c505t-8b93336e346bd025ab829e92894c353fbbb202b68672d68264ad947427ac54f03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Anti-Bacterial Agents - pharmacology</topic><topic>Antimicrobial susceptibility</topic><topic>Bacteriology</topic><topic>Biological and medical sciences</topic><topic>Biomarkers</topic><topic>Drug Resistance, Bacterial</topic><topic>Escherichia - classification</topic><topic>Escherichia - drug effects</topic><topic>Escherichia albertii</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Hafnia alvei</topic><topic>Hafnia alvei - classification</topic><topic>Hafnia alvei - drug effects</topic><topic>Infectious diseases</topic><topic>Medical sciences</topic><topic>Microbial Sensitivity Tests</topic><topic>Microbiology</topic><topic>Miscellaneous</topic><topic>Species Specificity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Stock, Ingo</creatorcontrib><creatorcontrib>Rahman, Motiur</creatorcontrib><creatorcontrib>Sherwood, Kimberley Jane</creatorcontrib><creatorcontrib>Wiedemann, Bernd</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Environmental Sciences and Pollution Management</collection><collection>MEDLINE - Academic</collection><jtitle>Diagnostic microbiology and infectious disease</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Stock, Ingo</au><au>Rahman, Motiur</au><au>Sherwood, Kimberley Jane</au><au>Wiedemann, Bernd</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Natural antimicrobial susceptibility patterns and biochemical identification of Escherichia albertii and Hafnia alvei strains</atitle><jtitle>Diagnostic microbiology and infectious disease</jtitle><addtitle>Diagn Microbiol Infect Dis</addtitle><date>2005-03-01</date><risdate>2005</risdate><volume>51</volume><issue>3</issue><spage>151</spage><epage>163</epage><pages>151-163</pages><issn>0732-8893</issn><eissn>1879-0070</eissn><coden>DMIDDZ</coden><abstract>Bangladeshi diarrheagenic Hafnia alvei-like strains have been described recently as the new species Escherichia albertii ( Int J Syst Evolut Microbiol. 2003;53:807–810). The natural susceptibility of 21 E. albertii and 76 H. alvei strains to 69 antimicrobial agents was examined, applying a microdilution procedure in IsoSensitest broth (for all the strains) and cation-adjusted Mueller-Hinton broth (for some strains). Examining the phenotypic features of both taxa with commercial identification systems and conventional tests, a database for an accurate biochemical separation of E. albertii from H. alvei was also established. Both taxa were naturally sensitive or sensitive and of intermediate susceptibility to aminoglycosides, acylureidopenicillins, ticarcillin, several cephalosporins, carbapenems, aztreonam, quinolones, folate pathway inhibitors, and nitrofurantoin. They were naturally resistant to tetracycline, penicillin G, oxacillin, all macrolides except for azithromycin, lincosamides, streptogramins, glycopeptides, rifampicin, and fusidic acid. Taxon-related differences in natural susceptibility affecting clinical assessment criteria were seen with doxycycline, minocycline, aminopenicillins, some cephalosporins, azithromycin, and fosfomycin. E. albertii was more susceptible than H. alvei to these agents and was naturally sensitive to all β-lactams (except for penicillin G and oxacillin), azithromycin, and fosfomycin. H. alvei was naturally resistant or of intermediate susceptibility to all tetracyclines, amoxicillin, amoxicillin-clavulanate, ampicillin-sulbactam, narrow-spectrum cephalosporins, azithromycin, and fosfomycin. Motile malonate-negative Hafnia strains (indicating genospecies 2 of the H. alvei complex) were less susceptible to some cephalosporins than nonmotile, malonate-positive hafniae (indicating genospecies 1). Proline deaminase, hydroxyproline amidase, tripeptidase, chitinase, Voges-Proskauer reaction, and assimilation of histidine as well as acid production from glycerol, rhamnose, and xylose were suitable tests to separate strains of E. albertii from those of the H. alvei complex. Although out of the scope of this study, it should be noted that several strains of E. albertii showed acquired resistances to some penicillins and antifolates.</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>15766600</pmid><doi>10.1016/j.diagmicrobio.2004.10.008</doi><tpages>13</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0732-8893
ispartof Diagnostic microbiology and infectious disease, 2005-03, Vol.51 (3), p.151-163
issn 0732-8893
1879-0070
language eng
recordid cdi_proquest_miscellaneous_67514154
source MEDLINE; Elsevier ScienceDirect Journals Complete
subjects Anti-Bacterial Agents - pharmacology
Antimicrobial susceptibility
Bacteriology
Biological and medical sciences
Biomarkers
Drug Resistance, Bacterial
Escherichia - classification
Escherichia - drug effects
Escherichia albertii
Fundamental and applied biological sciences. Psychology
Hafnia alvei
Hafnia alvei - classification
Hafnia alvei - drug effects
Infectious diseases
Medical sciences
Microbial Sensitivity Tests
Microbiology
Miscellaneous
Species Specificity
title Natural antimicrobial susceptibility patterns and biochemical identification of Escherichia albertii and Hafnia alvei strains
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T08%3A52%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Natural%20antimicrobial%20susceptibility%20patterns%20and%20biochemical%20identification%20of%20Escherichia%20albertii%20and%20Hafnia%20alvei%20strains&rft.jtitle=Diagnostic%20microbiology%20and%20infectious%20disease&rft.au=Stock,%20Ingo&rft.date=2005-03-01&rft.volume=51&rft.issue=3&rft.spage=151&rft.epage=163&rft.pages=151-163&rft.issn=0732-8893&rft.eissn=1879-0070&rft.coden=DMIDDZ&rft_id=info:doi/10.1016/j.diagmicrobio.2004.10.008&rft_dat=%3Cproquest_cross%3E67514154%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=17831889&rft_id=info:pmid/15766600&rft_els_id=S0732889304002299&rfr_iscdi=true